MoneyWorks4Me

Vivo Bio Tech gets nod to acquire Donakanti Consultancy Services

18 Apr 2019 Evaluate

Vivo Bio Tech has received approval from its board for acquiring 100% stake in Donakanti Consultancy Services. The current investment of Rs 3.18 crore, will help the company to acquire E-governance projects with the Government of India.

Vivo Bio Tech is a contract research company engaged in biotechnology and pharma drug discovery activities. VBTL provides services ranging from insilico design, wet lab contract research, preclinical research and clinical studies spanning the entire drug discovery value chain.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..